Boston Scientific Corporation (FRA:BSX)
89.00
-1.20 (-1.33%)
Oct 23, 2025, 5:04 PM CET
Boston Scientific Revenue
Boston Scientific had revenue of $5.07B USD in the quarter ending September 30, 2025, with 20.34% growth. This brings the company's revenue in the last twelve months to $19.35B, up 21.61% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$19.35B
Revenue Growth
+21.61%
P/S Ratio
8.04
Revenue / Employee
$365.08K
Employees
53,000
Market Cap
132.52B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.68B |
| Fielmann Group AG | 2.40B |
Boston Scientific News
- 14 hours ago - Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why - Nasdaq
- 17 hours ago - These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings - Benzinga
- 1 day ago - Boston Scientific (BSX) Surpasses Earnings Expectations in Q3 2025 - GuruFocus
- 1 day ago - Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ... - GuruFocus
- 1 day ago - Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum - Seeking Alpha
- 1 day ago - Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Q3 2025 Boston Scientific Corp Earnings Call Transcript - GuruFocus
- 1 day ago - Boston Scientific (BSX) Surpasses Q3 Estimates and Hikes Full-Year Outlook - GuruFocus